Benjamin D. Hedley
Special Hematology/Flow Cytometry
London Health Sciences Centre
Benjamin D. Hedley has not added Biography.
If you are Benjamin D. Hedley and would like to personalize this page please email our Author Liaison for assistance.
Therapeutic targets for antimetastatic therapy.
Expert opinion on therapeutic targets Dec, 2004 | Pubmed ID: 15584860
Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.
Future oncology (London, England) Oct, 2006 | Pubmed ID: 17026454
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Breast cancer research and treatment Nov, 2008 | Pubmed ID: 18097747
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
International journal of cancer. Journal international du cancer Aug, 2008 | Pubmed ID: 18470911
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.
Clinical & experimental metastasis , 2008 | Pubmed ID: 18543067
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Journal of cellular and molecular medicine Aug, 2009 | Pubmed ID: 18681906
Tumor dormancy and metastasis.
Advances in cancer research , 2009 | Pubmed ID: 19595307
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.
Clinical & experimental metastasis Mar, 2011 | Pubmed ID: 21234655
The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2011 | Pubmed ID: 21750199
Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2011 | Pubmed ID: 21856770
User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system.
Cytometry. Part A : the journal of the International Society for Analytical Cytology Nov, 2012 | Pubmed ID: 22899576
Response to Rossi et al.
Cytometry. Part A : the journal of the International Society for Analytical Cytology Jul, 2013 | Pubmed ID: 23788417
Determination of optimal replicate number for validation of imprecision using fluorescence cell based assays: Proposed practical method.
Cytometry. Part B, Clinical cytometry Jul, 2013 | Pubmed ID: 23873644
Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: Proposed practical method.
Cytometry. Part B, Clinical cytometry Sep, 2013 | Pubmed ID: 24022856
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
1London Regional Cancer Program, London Health Sciences Centre,
2Department of Anatomy & Cell Biology, Schulich School of Medicine and Dentistry, Western University,
3Special Hematology/Flow Cytometry, London Health Sciences Centre,
4, Lawson Health Research Institute,
5Department of Oncology, Western University
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved